Dr. Zachary Joe Berbos, MD

Dr. Berbos practices at Black Hills Regional Eye Surgery Center in Rapid City, South Dakota.

Dr. Berbos' NPI, 1497996433, was assigned on March 22, 2009. Dr. Berbos graduated from University Of Minnesota Medical School in 2006. Dr. Berbos holds South Dakota license 13158.

Dr. Berbos' primary practice is Black Hills Regional Eye Surgery Center, at 2800 Third Street, Rapid City, SD 57701. The practice phone is (605) 341-4100.

Dr. Berbos' primary practice is Black Hills Regional Eye Surgery Center in Rapid City, South Dakota. Dmand AI also links Dr. Berbos to 1 medical group, named with a free account. Dr. Berbos' employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berbos practices. Vendor and product names are available with a free account.

Ophthalmic plastic and reconstructive surgery is Dr. Berbos' primary specialty in the NPI Registry, under taxonomy code 207WX0200X. Dr. Berbos is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Berbos' licenses on file in 4 states: South Dakota, Wyoming, Arizona and Utah.

Dmand AI lists conjunctivitis, dry eye, eyelid inflammation and inflammation of iris among the conditions Dr. Berbos treats.

CMS data shows 4,432 Medicare services from Dr. Berbos across 27 procedure codes in 2024, for 590 Medicare patients. Medicare paid $319,347 for them.

CMS counts 590 Medicare patients who saw Dr. Berbos in 2024. The largest group is 65 to 74, with 320 patients. 67% of them have high blood pressure, and 65% have high cholesterol. 7% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Berbos' median patient age at 74, with 63% women.

In 2024, Dr. Berbos wrote 1,078 Medicare Part D claims for 469 patients. 68% of them were for generic drugs. CMS names the drug for 1,031 of them, across 8 drugs with 11 or more claims each, at $11,213 in total drug cost. In 2023, CMS named 732 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Berbos for performance year 2024, reported as part of a group. Dr. Berbos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 58 procedures of melanoma (skin cancer) excision by Dr. Berbos, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Berbos in 2011. The most frequent topics are Botulinum Toxins, Type A, Eyelid Diseases and Eyelids. Dr. Berbos has published most often in Ophthalmic Plast Reconstr Surg. Dr. Berbos' most frequent co-authors are Andrew Richard Harrison, MD, Michael S. Lee, MD and Ilya M. Leyngold, MD.

CMS Open Payments shows 19 general payments to Dr. Berbos from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $143.

Dmand AI lists 1 award for Dr. Berbos, most recently CMS Stage 1 EHR in 2013.

Dr. Berbos graduated from University Of Minnesota Medical School in 2006.

Dr. Berbos is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.